SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001079973-24-000177
Filing Date
2024-02-08
Accepted
2024-02-08 07:30:10
Documents
15
Period of Report
2024-02-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K opgen_8k.htm   iXBRL 8-K 25351
2 FORM OF SECOND AMENDMENT AGREEMENT TO WARRANT INDUCEMENT ex10x1.htm EX-10.1 12911
  Complete submission text file 0001079973-24-000177.txt   213327

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE opgn-20240207.xsd EX-101.SCH 3006
4 XBRL LABEL FILE opgn-20240207_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE opgn-20240207_pre.xml EX-101.PRE 22353
16 EXTRACTED XBRL INSTANCE DOCUMENT opgen_8k_htm.xml XML 3574
Mailing Address 9717 KEY WEST AVENUE SUITE 100 ROCKVILLE MD 20850
Business Address 9717 KEY WEST AVENUE SUITE 100 ROCKVILLE MD 20850 301-869-9683
OPGEN INC (Filer) CIK: 0001293818 (see all company filings)

IRS No.: 061614015 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37367 | Film No.: 24606863
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)